122 related articles for article (PubMed ID: 1377433)
1. [Benign prostatic hyperplasia and growth factors: mechanisms and hypotheses].
Aumüller G
Urologe A; 1992 May; 31(3):159-65. PubMed ID: 1377433
[TBL] [Abstract][Full Text] [Related]
2. Stromal cells of the human prostate: initial isolation and characterization.
Kassen A; Sutkowski DM; Ahn H; Sensibar JA; Kozlowski JM; Lee C
Prostate; 1996 Feb; 28(2):89-97. PubMed ID: 8604397
[TBL] [Abstract][Full Text] [Related]
3. Regulation of prostatic growth and function by peptide growth factors.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Hittmair A; Zhang J; Thurnher M; Bartsch G; Klocker H
Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
5. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
Gao J; Arnold JT; Isaacs JT
Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
[TBL] [Abstract][Full Text] [Related]
6. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
7. Benign prostatic hyperplasia and growth factors.
Lawson RK
Urologe A; 1990 Jan; 29(1):5-7. PubMed ID: 1690485
[TBL] [Abstract][Full Text] [Related]
8. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
[TBL] [Abstract][Full Text] [Related]
9. FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasia.
Polnaszek N; Kwabi-Addo B; Wang J; Ittmann M
Prostate; 2004 Jun; 60(1):18-24. PubMed ID: 15129425
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia: age-related tissue-remodeling.
Untergasser G; Madersbacher S; Berger P
Exp Gerontol; 2005 Mar; 40(3):121-8. PubMed ID: 15763388
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
Wang W; Zhang X; Mize GJ; Takayama TK
Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
[TBL] [Abstract][Full Text] [Related]
12. Heparin-binding epidermal growth factor-like growth factor is an autocrine mediator of human prostate stromal cell growth in vitro.
Duque JL; Adam RM; Mullen JS; Lin J; Richie JP; Freeman MR
J Urol; 2001 Jan; 165(1):284-8. PubMed ID: 11125426
[TBL] [Abstract][Full Text] [Related]
13. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
14. Regulation of basic fibroblast growth factor expression by transforming growth factor beta in cultured human prostate stromal cells.
Story MT; Hopp KA; Meier DA
Prostate; 1996 Apr; 28(4):219-26. PubMed ID: 8602397
[TBL] [Abstract][Full Text] [Related]
15. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
16. FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells.
Giri D; Ropiquet F; Ittmann M
J Cell Physiol; 1999 Jul; 180(1):53-60. PubMed ID: 10362017
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen and benign prostatic hyperplasia: effects on stromal cell proliferation and local formation from androgen.
Ho CK; Nanda J; Chapman KE; Habib FK
J Endocrinol; 2008 Jun; 197(3):483-91. PubMed ID: 18492814
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor induces proliferation of hyperplastic human prostatic stromal cells.
Vlahos CJ; Kriauciunas TD; Gleason PE; Jones JA; Eble JN; Salvas D; Falcone JF; Hirsch KS
J Cell Biochem; 1993 Aug; 52(4):404-13. PubMed ID: 7693727
[TBL] [Abstract][Full Text] [Related]
20. An orthotopic model for the study of growth factors in the ventral prostate of the rat: effects of epidermal growth factor and basic fibroblast growth factor.
Marengo SR; Chung LW
J Androl; 1994; 15(4):277-86. PubMed ID: 7982795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
